Stockreport

Definium Therapeutics to Participate at Upcoming Investor Conferences and Events

Definium Therapeutics, Inc. - Common Shares  (DFTX) 
PDF NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics in [Read more]